Brief: India's Orchid Pharma March Quarter Loss Narrows
03/06/2019 14:48
June 3 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* MARCH QUARTER LOSS FROM CONTINUING OPERATIONS 134.5
MILLION
RUPEES VERSUS LOSS 923.7 MILLION RUPEES YEAR AGO
* MARCH QUARTER INCOME FROM OPERATIONS 1.62 BILLION RUPEES
VERSUS
1.56 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEb9ysH0
Further company coverage: ORCD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices